Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Predictive Value of Quantified Indocyanine Green Fluorescent Angiography for Skin Necrosis in Mastectomy With Immediate Reconstruction

NCT06956443 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT06956443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06956443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Predictive Value of Quantified Indocyanine Green Fluorescent Angiography for Skin Necrosis in Mastectomy With Immediate Reconstruction
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2025
Completion date
December 1, 2026
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancers, mastectomy and breast reconstruction, skin necrosis